The Pathogenesis and Prognostic Factors of Lymphoma

Fudan University logo

Fudan University

Status

Enrolling

Conditions

Hodgkin Lymphoma
Non-hodgkin Lymphoma
Lymphoma

Treatments

Other: Real-world regimen

Study type

Observational

Funder types

Other

Identifiers

NCT06203652
SHZS-lym-001

Details and patient eligibility

About

The aim of this study is to describe the clinical and genetic characteristics of Chinese lymphoma patients, and to explore the relationship between those characteristics and phatogenesis.

Full description

Lymphoma is a highly common malignant tumor in Asia. This study aims to observe and describe the clinical and genetic charateristics of Chinese lymphoma patients, and to explore the relationship between those charateristics and pathogenesis and prognostic factors in the real-world population. This study is a non-interventional real world, observational study and all registered data are collected from real clinical practice cases. The medical data includes patient demographic, tumor characteristics, laboratory examination, history of treatments, adverse reactions, efficacy results and possible prognostic factors.

Enrollment

2,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with pathological diagnosis of lymphoma (including Hodgkin lymphoma and non-Hodgkin lyphoma, eg. THRLBCL, DLBCL, MZL, CLL/SLL...) from 2007 to 2027.
  • Patients with complete diagnostic, treatment and follow-up records.
  • Fully comprehension and signature of the informed consent form (ICF) for participation.

Exclusion criteria

  • Those who refuse to use reliable methods of contraception during pregnancy, lactation or age-appropriate period.
  • Severe mental illness.
  • Patients deemed unsuitable for inclusion by the investigator.

Trial design

2,000 participants in 1 patient group

All enrolled patients
Description:
All patients who are eligible for participation to the study.
Treatment:
Other: Real-world regimen

Trial contacts and locations

1

Loading...

Central trial contact

Peng Liu, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems